Merck & Co Inc MRK:NYSE
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 56.80 | 0.06 0.11% | 3.10% | 10,140,975 | 8.3M |
Market data is delayed by at least 20 minutes.
Quarterly Earnings Per Share
8/3/2014 5:29 PM ET
| Market Comparison | P/E (TTM) | P/E (Forward 12 Months) | PEG | 1 Year EPS Growth Rate | 5 Year EPS Growth Rate |
| MRK Merck & Co Inc | 29.9 | -- | 7.4 | -26.66% | -16.56% |
| Biotechnology & Drugs Industry | -- | 17.3 | 7.2 | -19.85% | 5.18% |
| Healthcare Sector | 30.6 | 16.1 | 5.4 | 0.04% | 6.27% |
| S&P; 500 | 18.4 | 20.7 | 3.4 | 16.78% | 11.99% |
Loading...
Earnings Summary
On 7/29/2014, MRK reported 2 quarter 2014 earnings of $0.85 per share. This result was in-line with the consensus of the 16 analysts following the company and beat last year's 2 quarter results by 1.19%.
MRK's PE ratio is above average for the Biotechnology & Drugs industry and signals that investors are willing to pay a premium for this stock. However, during the past year, earnings growth has lagged its historical five year growth rate.